The Pennington Biomedical Research Center is a health science-focused research center in Baton Rouge, Louisiana
The Latest Bing News on:
Pennington Biomedical Research Center Research
- Heart Benefits of Ozempic Evident Regardless of Weight Loss, Research Suggests
Ozempic and Wegovy, which are based on the active ingredient semaglutide, may provide notable advantages for cardiac health, including a decreased risk of stroke or heart attack, irrespective of any ...
- LSU investing in 27 faculty research projects
LSU Provost’s Fund for Innovation in Research is investing $1.2 million to fund 27 projects at the university.
- Q&A: Researcher discusses changing the pregnancy culture to 'eating for you,' not for two
For many generations, society has embraced the idea that pregnant women are "eating for two." That adage is frequently invoked as mothers-to-be are encouraged to abandon diets and overindulge in every ...
- Dr. Leanne Redman to lead Pennington Biomedical's Nutrition Obesity Research Center
Dr. Leanne Redman has been named as the new director of Pennington Biomedical's Nutrition Obesity Research Center, or NORC. On May 1, Dr. Redman took over the role from Dr. Eric Ravussin, who held the ...
- Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
The Latest Bing News on:
Pennington Biomedical Research Center Discovery
- Heart Benefits of Ozempic Evident Regardless of Weight Loss, Research Suggests
Ozempic and Wegovy, which are based on the active ingredient semaglutide, may provide notable advantages for cardiac health, including a decreased risk of stroke or heart attack, irrespective of any ...
- Dr. Leanne Redman to lead Pennington Biomedical's Nutrition Obesity Research Center
Dr. Leanne Redman has been named as the new director of Pennington Biomedical's Nutrition Obesity Research Center, or NORC. On May 1, Dr. Redman took over the role from Dr. Eric Ravussin, who held the ...
- Patients who took Wegovy usually kept significant weight off
“Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments to cover the ...
- Everything you need to know about semaglutide weight loss drugs
From how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by blocking a hormone that normally reduces appetite ...
- Weight Loss Drugs Slash Heart Attack Risk, Says Study
Research showed promising results for semaglutide (Wegovy) in reducing heart risks for obese patients already battling cardiovascular diseases.